Search In this Thesis
   Search In this Thesis  
العنوان
Assessment of troponin i level as a marker of myocardial injury in patients with chronic hepatitis c virus infection /
المؤلف
El-Nagar, Mohamed Mohamed Hamed.
هيئة الاعداد
باحث / محمد محمد حامد النجار
مشرف / رغدة السيد فرج
مشرف / محمد السيد العرمان
مشرف / سحر زكريا حسن
مناقش / السعيد جلال البدراوي
مناقش / منى محمود عرفه
الموضوع
Myocardial infarction. Hepatitis C. Chronic Disease. Hepatitis, Viral.
تاريخ النشر
2017.
عدد الصفحات
85 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب (متفرقات)
تاريخ الإجازة
01/07/2017
مكان الإجازة
جامعة المنصورة - كلية الطب - Department of Tropical Medicine
الفهرس
Only 14 pages are availabe for public view

from 98

from 98

Abstract

Hepatitis C virus (HCV) is a progressive disease that may resultin chronic active hepatitis , cirrhosis, and hepatocellular carcinoma. It isestimated that over 200 million people are infected worldwide, while80% develop a chronic form. Egypt has the highest prevalence of hepatitis C virus (HCV) in theworld, estimated nationally at 14.7% . chronichepatitis c virus infection may be associated with many extrahepatic manifestations including cryoglobulinemia, lymphoma,thyroiditisandmembranoproliferative glomerulonephritis. In addition, causal relationship with HCV infection has been suspected for several myocardial impairments including; dilated cardiomyopathy,hypertophic cardiomyopathy and chronic myocarditis . The pathogenesis of these HCV- associated myocardial impairments probably rely on autoimmune phenomena with particular involvement of the human major histocompatibility (MHC) Class II antigen. Troponin I is a sensitive and specific marker of myocardial injury. Elevated troponin levels are associated with a significant increase in morbidity and mortality. So, measurement of troponin I levels may be helpful in patients with chronic hepatitis c virus patients to detect unrecognized myocardial damage . This study carried out on 40 adult patients with chronic hepatitis c virus infection.In addition, twenty healthy control subjects.